NEW YORK, Sept. 25, 2012 (GLOBE NEWSWIRE) -- Context Matters, a next generation healthcare data and analytics company focusing on risk assessment metrics for pharmaceutical and biotechnology products, announces the wide release of its proprietary data platform, the Reimbursement Risk Tracker™, which provides pharmaceutical and biotechnology customers with unprecedented access to information for clinical development, drug reimbursement, regulatory considerations and pricing.
The Reimbursement Risk Tracker enables Context Matters clients to drill down into a reimbursement context to understand restrictions on reimbursement, clinical and economic outcome thresholds and the disease prevalence and indications for 35 disease conditions. The product covers more than 500 complex variables across more than 100 global sources of data, delivering, directly to users, standard reports, customized analysis, the ability to identify favorites and a completely scalable and flexible tool that allow users to relate and compare data sets – including data on orphan indications – that may have not been compared previously, all in a controlled and user-friendly product.
"Our Reimbursement Risk Tracker provides our customers with first-hand access to a sophisticated, customizable and constantly updated database system to help answer their most complex strategic questions in a more comprehensive way than has ever been seen before," said Yin Ho, MD, MBA, CEO of Context Matters. "Our platform culls more data sources, and provides better insights that will help pharmaceutical and biotechnology companies more effectively compete in a market where the ultimate profitable goal is reimbursement."
The Reimbursement Risk Tracker is already being utilized by two top-five global pharmaceutical companies.
Context Matters, Inc. is the next generation of healthcare data analytics, focusing on risk assessment metrics for pharmaceutical and biotechnology products. Its data-driven /evidence-based approach begins with a proprietary software database platform of intelligently culled, curated, and relevant business information and data to answer strategic business questions and provide actionable analysis. Its platform and approach result in more informed decision-making by allowing users to access and understand complex data that has never before been quantified or aggregated through a tailored, needs-based approach.